Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593888 | SCV000700858 | pathogenic | not provided | 2015-07-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001383849 | SCV001583158 | pathogenic | GNE myopathy; Sialuria | 2023-05-21 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 496957). This variant has not been reported in the literature in individuals affected with GNE-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg233Hisfs*7) in the GNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNE are known to be pathogenic (PMID: 24027297). |
Baylor Genetics | RCV004568310 | SCV005059629 | likely pathogenic | GNE myopathy | 2023-11-02 | criteria provided, single submitter | clinical testing |